Search results for "Replacement"

showing 10 items of 561 documents

Anderson-Fabry Disease: A Multiorgan Disease

2013

Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A . FD causes glycolipids, such as globotriaosylceramide (Gb3), to accumulate in the vascular endothelium of several organs (fig.2), including the skin, kidneys, nervous system, and heart, thereby triggering inflammation and fibrosis . These processes generally result in organ dysfunction, which is usually the first clinical evidence of FD. Patients with classic FD have various symptoms, eg, acroparesthesias, hypohidrosis, angiokeratomas, corneal opacities, cerebrovascular lesions, cardiac disorders, andrenal dysfunction.However, evolving knowledge about the natural course o…

Central Nervous SystemMalePathologymedicine.medical_specialtySettore MED/09 - Medicina InternaGlobotriaosylceramideDiseaseKidneySeverity of Illness IndexAnderson-Fabry disease multiorgan lysosomialNephropathychemistry.chemical_compoundDrug DiscoverymedicineHumansEnzyme Replacement TherapyEndothelial dysfunctionSkinPharmacologySex Characteristicsbusiness.industryOrgan dysfunctionAge FactorsKidney metabolismEnzyme replacement therapymedicine.diseaseFabry diseasechemistryQuality of LifeFabry DiseaseFemalemedicine.symptombusinessCurrent Pharmaceutical Design
researchProduct

CNS manifestations of Fabry's disease

2006

Summary Background Fabry's disease is a rare hereditary lysosomal storage disease with multiorgan involvement. Deficiency of α-galactosidase A activity leads to accumulation of neutral glycosphingolipids, especially in vascular endothelial and smooth-muscle cells. Along with progressive renal and cardiac dysfunction, stroke is a major and often life-threatening burden of the disease. Cerebral vasculopathy, confirmed by neuropathological, neuroradiological, and functional studies, occurs commonly and leads to ischaemic cerebrovascular events at an early age. Recent developments Fabry's disease is an X-linked disease and women have been regarded as only mildly affected carriers. However, rese…

Central Nervous SystemPediatricsmedicine.medical_specialtyPathologybusiness.industryBrainEnzyme replacement therapyDiseaseTransient ischaemic attacksmedicine.diseaseFabry's diseaseFabry diseaseStrokeCerebrovascular DisordersmedicineLysosomal storage diseaseFabry DiseaseHumansNeurology (clinical)Young adultbusinessStrokeThe Lancet Neurology
researchProduct

Transcranial Magnetic Stimulation Combined With Nicotine Replacement Therapy for Smoking Cessation: A Randomized Controlled Trial.

2015

Abstract Background Further evidence suggests that repetitive Transcranial Magnetic Stimulation (rTMS) is an effective method to reduce tobacco craving among smokers. Hypothesis As relapse is common within a few days after smoking cessation, we hypothesized that combining the anti-craving effects of rTMS with Nicotine replacement therapy (NRT) to attenuate withdrawal symptoms could increase abstinence rates in smokers with severe nicotine dependence who quit smoking. Methods Thirty-seven smokers who failed to quit with the usual treatments were randomly assigned to two treatment groups to receive either active ( n  = 18) or sham ( n  = 19) 1-Hz rTMS of the right dorsolateral prefrontal cort…

CessationAdultMaleNicotinemedicine.medical_specialtymedicine.medical_treatmentmedia_common.quotation_subjectBiophysicsPrefrontal CortexCravingbehavioral disciplines and activitieslcsh:RC321-571law.inventionNicotineYoung AdultRandomized controlled triallawTobaccomental disordersmedicineHumansSingle-Blind MethodPsychiatrylcsh:Neurosciences. Biological psychiatry. Neuropsychiatrymedia_commonCravingGeneral NeuroscienceTobacco Use DisorderAbstinenceMiddle AgedNicotine replacement therapyCombined Modality TherapyTranscranial Magnetic StimulationTobacco Use Cessation DevicesTranscranial magnetic stimulationTreatment Outcomenervous systemAnesthesiaCombinationbehavior and behavior mechanismsSmoking cessationFemaleSmoking CessationNeurology (clinical)medicine.symptomTobacco Use Cessation ProductsPsychologypsychological phenomena and processesmedicine.drugBrain stimulation
researchProduct

Ovarian tissue cryopreservation and transplantation in menopause: new perspective of therapy in postmenopausal women and the importance of ethical an…

2023

Menopausal transition entails a progressive decrease in hormone production by the ovaries that lead to important physical and psychological changes that could significantly affect quality of life. Hormone replacement therapy (HRT) administered from the onset of menopausal symptoms usually improves quality of life and life expectancy. Nevertheless, it is not risk-free. Ovarian tissue cryopreservation (OTC) has been investigated as a potential new strategy for delaying menopause and/or to avoid HRT. This review analyzes the critical points of HRT to assess whether OTC and subsequent reimplantation can affect postmenopausal management. We assessed available randomized clinical trials in PubMed…

CryopreservationCounselingTransplantationEstrogen Replacement TherapyEstrogensGuidelinesHormone replacement therapy (HRT)Settore MED/40 - Ginecologia E OstetriciaPostmenopauseOvarian tissue cryopreservation (OTC)Medicolegal viabilityQuality of LifeHumansOsteoporosisFemaleMenopause
researchProduct

The short-term efficacy and safety of artificial total disc replacement for selected patients with lumbar degenerative disc disease compared with ant…

2018

PurposeTo systematically compare the efficacy and safety of lumbar total disc replacement (TDR) with the efficacy and safety of anterior lumbar interbody fusion (ALIF) for the treatment of lumbar degenerative disc disease (LDDD).MethodsThe electronic databases PubMed, Web of Science and the Cochrane Library were searched for the period from the establishment of the databases to March 2018. The peer-reviewed articles that investigate the safety and efficacy of TDR and ALIF were retrieved under the given search terms. Quality assessment must be done independently by two authors according to each item of criterion. The statistical analyses were performed using RevMan (version 5.3) and Stata (v…

Databases FactualIntervertebral Disc DegenerationCochrane Librarylaw.inventionDatabase and Informatics MethodsMathematical and Statistical Techniques0302 clinical medicineRandomized controlled triallawMedicine and Health SciencesRange of Motion ArticularDatabase Searching030222 orthopedicsMultidisciplinaryQStatisticsRMetaanalysisResearch AssessmentHospitalsTreatment OutcomeResearch DesignMeta-analysisPhysical SciencesObservational StudiesMedicineRange of motionResearch ArticleTotal Disc Replacementmedicine.medical_specialtySystematic ReviewsClinical Research DesignScienceSurgical and Invasive Medical ProceduresResearch and Analysis MethodsDegenerative disc disease03 medical and health sciencesLumbarmedicineHumansStatistical Methodsbusiness.industryEvidence-based medicinemedicine.diseaseSurgeryHealth CareSpinal FusionHealth Care FacilitiesObservational studyAdverse EventsbusinessPublication BiasMathematics030217 neurology & neurosurgeryPLOS ONE
researchProduct

Attenuated mucopolysaccharidosis: are you missing this debilitating condition?

2011

Diagnosis DifferentialRheumatologybusiness.industryMucopolysaccharidosisMedicineHumansPharmacology (medical)Enzyme Replacement TherapyMucopolysaccharidosesBioinformaticsbusinessmedicine.diseaseRheumatology (Oxford, England)
researchProduct

Safety study of sodium pentosan polysulfate for adult patients with mucopolysaccharidosis type II

2019

Current therapies for the mucopolysaccharidoses (MPS) do not effectively address skeletal and neurological manifestations. Pentosan polysulfate (PPS) is an alternative treatment strategy that has been shown to improve bone architecture, mobility, and neuroinflammation in MPS animals. The aims of this study were to a) primarily establish the safety of weekly PPS injections in attenuated MPS II, b) assess the efficacy of treatment on MPS pathology, and c) define appropriate clinical endpoints and biomarkers for future clinical trials. Subcutaneous injections were administered to three male Japanese patients for 12 weeks. Enzyme replacement therapy was continued in two of the patients while th…

Drug0301 basic medicinemedicine.medical_specialtymedia_common.quotation_subjectEndocrinology Diabetes and MetabolismClinical BiochemistryeducationUrologymucopolysaccharidosis IIBiochemistryArticlePPSrange of motion03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineClinical endpointglycosaminoglycanGeneticsMedicineMucopolysaccharidosis type IIAdverse effectMolecular Biologyhealth care economics and organizationsmedia_commonbiologyAdult patientsanti-inflammatory factorbusiness.industryEnzyme replacement therapyPentosan polysulfateClinical trial030104 developmental biologyAlanine transaminasebiology.proteinSodium Pentosan Polysulfatebusiness030217 neurology & neurosurgerymedicine.drugMolecular Genetics and Metabolism
researchProduct

Menopause and diabetes: EMAS clinical guide

2018

Abstract Introduction Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independently of ageing has been a matter of debate. Controversy also exists about the benefits and risks of menopausal hormone therapy (MHT) in women with T2DM. Aims To summarise the evidence on 1) the effect of menopause on metabolic parameters and the risk of T2DM, 2) the effect of T2DM on age at menopause, 3) the effect of MHT on the risk of T2DM, and 4) the management of postmenopausal women with T2DM. Materials and methods Literature review and consensus of experts’ opinions. Results and conclusion Metabolic changes during the menopausal transition include an increase in and the central redis…

ESTROGEN REPLACEMENTmedicine.medical_specialtyHORMONE-REPLACEMENT THERAPYendocrine system diseasesmedicine.medical_treatment030209 endocrinology & metabolismDiseaseDydrogesteroneGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicine3123 Gynaecology and paediatricsRisk FactorsInternal medicineDiabetes mellitusType 2 diabetes mellitusDiabetes MellitusmedicineHumansNATURAL MENOPAUSEMenopausal hormone therapy; Menopause; Type 2 diabetes mellitus; Estrogen Replacement Therapy; Female; Humans; Incidence; Risk Factors; Diabetes Mellitus Type 2; MenopauseESTRADIOLMETABOLIC SYNDROME030219 obstetrics & reproductive medicineProgestogenINSULIN SENSITIVITYbusiness.industryIncidenceEstrogen Replacement TherapyENERGY-EXPENDITUREnutritional and metabolic diseasesObstetrics and GynecologyType 2 Diabetes MellitusHormone replacement therapy (menopause)medicine.disease3. Good healthMenopausePOSTMENOPAUSAL WOMENDiabetes Mellitus Type 23121 General medicine internal medicine and other clinical medicineRISK-FACTORSFemaleHEALTHMenopauseMetabolic syndromebusinessType 2Menopausal hormone therapymedicine.drug
researchProduct

Analysis of different geometrical features to achieve close-to-bone stiffness material properties in medical device: A feasibility numerical study

2021

Background and objective: In orthopedic medical devices, elasto-plastic behavior differences between bone and metallic materials could lead to mechanical issues at the bone-implant interface, as stress shielding. Those issue are mainly related to knee and hip arthroplasty, and they could be responsible for implant failure. To reduce mismatching-related adverse events between bone and prosthesis mechanical properties, modifying the implant's internal geometry varying the bulk stiffness and density could be the right approach. Therefore, this feasibility study aims to assess which in-body gap geometry improves, by reducing, the bulk stiffness. Methods: Using five finite element models, a unia…

Elastic ModulusArthroplasty Replacement HipIn-body gapsFinite Element AnalysisFeasibility StudiesHealth InformaticsStress MechanicalArthroplasty Replacement KneeSoftwareComputer Science ApplicationsMaterial stiffness
researchProduct

Finite element analysis of two total knee joint prostheses

2012

Aim of this work is to compare two different total knee prostheses that differ mainly in the shape of the polyethylene (PE) component inserted between the femoral and tibial plates. The best solution between them has been originally reshaped in order to reduce stress peaks. The study procedure has been divided into the following steps. First step is the digitalisation of the shape of the prostheses by means of a 3D laser scanner. The morphology of two prototypes of the prostheses has been acquired by elaborating multiple Moire fringe patterns projected on their surfaces. Second step consisted on the manipulation of these data in a CAD module, that is the interpolation of raw data into NURBS…

Engineeringbusiness.industrymedicine.medical_treatmentContact analysisCADKinematicsStructural engineeringProsthesisIndustrial and Manufacturing EngineeringFinite element methodStress (mechanics)Modeling and SimulationmedicineTotal knee replacement FEM simulation Contact analysisbusinessReduction (mathematics)Biomedical engineeringInterpolation
researchProduct